This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Cancer Therapeutics Crc Pty Limited. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: The Innovations of Inventor Gillian Elizabeth Lunniss
Introduction: Gillian Elizabeth Lunniss, a talented inventor based in Parkville, AU, has made significant contributions to the field of pharmaceuticals with her groundbreaking patents.
Latest Patents: Gillian Elizabeth Lunniss holds six patents, with her latest inventions focusing on 2-(hetero)aryl-benzimidazole and imidazopyridine derivatives as inhibitors of asparagine methyl transferase, as well as VEGFR3 inhibitors for the treatment of proliferative diseases like cancer.
Career Highlights: Gillian Elizabeth Lunniss is a key figure at Cancer Therapeutics CRC Pty Limited, where she utilizes her expertise to develop innovative pharmaceutical solutions for treating cancer and hemoglobinopathies.
Collaborations: In her professional journey, Gillian Elizabeth Lunniss has collaborated with esteemed colleagues such as Ian Peter Holmes and Richard Charles Foitzik, synergizing their efforts to drive advancements in the pharmaceutical industry.
Conclusion: Gillian Elizabeth Lunniss' relentless pursuit of innovation and her remarkable patents in the field of pharmaceuticals showcase her as a trailblazing inventor making a profound impact on the healthcare landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile